Consumer neural data outside medical rules
A conditional statement under stated assumptions, never a prediction.
Contents
- ·Edition home
- ·Executive summary
- 1Neurotechnology is clinical hardware and a new class of personal data
- 2Key findings
- 3Systems and sectors at baseline
- 4Risks and capability
- 5Consumer neural data outside medical rules
- 6Readings from the other desks
- 7The 2027 agenda
- 8Systems in depth
- AMethodology
- BData appendix
- CReferences and record
- ·Complete edition, for print
5.1Assumptions
Scenario SCN-XT20-NDT-01: what is assumed, and what is held constant.
- Baseline
- the 2026 reference state in this edition
- Drivers
- consumer neural devices spread faster than rules, while decoders improve at inferring intent
- Analogues
- the 2023 Chilean deletion order and the 2024 Colorado law1417
- Interventions
- none modelled: the specification describes the unmitigated case
- Run state
- narrative specification; quantified run scheduled for 2027
5.2The cascade, step by step
- 1
INF → DAT
decoders reach inner speech in research settings
2025
- 2
DAT → GOV
states and bodies add neural data to privacy law
2024
- 3
GOV → FIN
companies face rules that differ by jurisdiction
2025
- 4
FIN → INF
funding favours clinical devices with clear pathways
2025
- 5
DAT → HLT
consumer devices that infer mood or intent fall outside medical oversight
2024
- 6
GOV → DAT
a federal study reports on gaps in existing law
2025
5.3The scenario as a table of steps
How the shock in scenario SCN-XT20-NDT-01 would travel through Neurotechnology and Human–Machine Interfaces’s coupled systems, step by step, under the assumptions the edition states.
| Step | What happens | Source |
|---|---|---|
| 01 Infrastructure to dat | Decoders reach inner speech in research settings. Analogue or source: 2025. | Edition XT-20, scenario SCN-XT20-NDT-01, step 1 |
| 02 DAT to governance | States and bodies add neural data to privacy law. Analogue or source: 2024. | Edition XT-20, scenario SCN-XT20-NDT-01, step 2 |
| 03 Governance to finance | Companies face rules that differ by jurisdiction. Analogue or source: 2025. | Edition XT-20, scenario SCN-XT20-NDT-01, step 3 |
| 04 Finance to infrastructure | Funding favours clinical devices with clear pathways. Analogue or source: 2025. | Edition XT-20, scenario SCN-XT20-NDT-01, step 4 |
| 05 DAT to health | Consumer devices that infer mood or intent fall outside medical oversight. Analogue or source: 2024. | Edition XT-20, scenario SCN-XT20-NDT-01, step 5 |
| 06 Governance to dat | A federal study reports on gaps in existing law. Analogue or source: 2025. | Edition XT-20, scenario SCN-XT20-NDT-01, step 6 |
A teaching model of a conditional scenario under the edition’s stated assumptions: not a forecast, not a prediction and not a warning. Sources: Neurotechnology and Human–Machine Interfaces 2026, scenario SCN-XT20-NDT-01 (2026); Neurotechnology and Human–Machine Interfaces 2026, references (NR-CIT-1) (2026).
Notes
Numbers are the edition’s reference numbers, so a note reads the same in every chapter. The full list, with every source and its licence, is in Annex C. Annex C, references
- 14Colorado General Assembly (ed.), HB24-1058 Protect Privacy of Biological Data (bill page read: signed 17 April 2024; effective 7 August 2024). Colorado General Assembly, Denver. Observation year 2024. Accessed 2026-11-03.back
- 17Cornejo-Plaza, M.I., Cippitani, R. and Pasquino, V., Chilean Supreme Court ruling on the protection of brain activity: neurorights, personal data protection, and neurodata, Frontiers in Psychology 15, 27 February 2024 (reference record read). Frontiers Media, Lausanne. Observation year 2024. Accessed 2026-11-03.back
